Fortress Biotech (FBIO) Cash & Equivalents (2010 - 2026)
Fortress Biotech (FBIO) posted Cash & Equivalents of $196.58 million for Q2 2026, up 164.3% from $74.39 million a year earlier.
Powered by 
Analysis
Fortress Biotech (FBIO) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Fortress Biotech's Cash & Equivalents came in at $79.38 million, up 38.6% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -19.4% (FY2020 to FY2025).
- In prior years, Fortress Biotech's Cash & Equivalents was $57.26 million in FY2024 (-29.2%), $80.93 million in FY2023 (-54.6%), $178.27 million in FY2022 (-41.7%) and $305.74 million in FY2021 (+31.0%).
- The Q2 2026 figure stands as the highest quarterly Cash & Equivalents since Q3 2022.
- On a year-over-year basis, Cash & Equivalents increased in four of the last seven quarters, with growth averaging 29.7%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q2 2026, with growth of 164.3%; the weakest was Q2 2023, with a decline of 68.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Fortress Biotech | 71.29 Mn | -323.33 Mn | 12.58 Mn | 196.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 196.58 Mn |
| Dec 31, 2025 | 79.38 Mn |
| Sep 30, 2025 | 86.22 Mn |
| Jun 30, 2025 | 74.39 Mn |
| Mar 31, 2025 | 91.34 Mn |
| Dec 31, 2024 | 57.26 Mn |
| Sep 30, 2024 | 58.85 Mn |
| Jun 30, 2024 | 76.20 Mn |
| Mar 31, 2024 | 83.77 Mn |
| Dec 31, 2023 | 80.93 Mn |
| Sep 30, 2023 | 72.31 Mn |
| Jun 30, 2023 | 78.02 Mn |
| Mar 31, 2023 | 152.48 Mn |
| Dec 31, 2022 | 178.27 Mn |
| Sep 30, 2022 | 208.35 Mn |
| Jun 30, 2022 | 248.77 Mn |
| Mar 31, 2022 | 287.51 Mn |
| Dec 31, 2021 | 305.74 Mn |
| Sep 30, 2021 | 252.72 Mn |
| Jun 30, 2021 | 274.99 Mn |
API Access
Fortress Biotech Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=FBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "FBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=FBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();